7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one CAS: 148870-57-9
| Product Parameters | |
|---|---|
| Catalog No. | BK8YQ4 |
| CAS.RN | 148870-57-9 |
| Molecular Formula | C15H18INO3 |
| Molecular Weight | 387.21 g/mol |
| Purity | NLT 98% |
Product Overview
7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzozazepine-2-one is a structurally complex pharmaceutical intermediate widely used in the construction and synthesis of novel drug molecules. This compound possesses a well-defined chemical structure and stable functional group characteristics, making it suitable for key stages in organic synthesis, drug development, and process development. It can meet diverse customer needs in small-scale, pilot-scale, and industrial-scale production during the R&D phase, and is an important precursor for the synthesis of drugs containing benzozazepine skeletons, applicable to the R&D and production processes of various innovative and generic drugs.
Applications
- Drug molecule construction and synthesis
- Customized intermediate preparation
- Process route development and optimization
- Support for innovative drug R&D projects
- Chemically patent-protected synthesis
Quality & Supply Capability
English Name: 7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one Properties: This product is a white to off-white solid containing two methoxy substituents and one iodopropyl side chain. It exhibits good chemical stability and reactivity, making it suitable for various organic synthesis reaction systems. Storage Recommendations: Store in a sealed, light-protected, and dry place, referring to the COA/MSDS for specific requirements. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging Documentation Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process supply service from laboratory samples to industrial-scale production, covering small-scale preparation, pilot-scale amplification, and customized batch production. We can flexibly adjust purity standards, impurity control requirements, packaging specifications, and delivery cycles according to customer needs, while providing complete quality documentation support. We also offer technical support from laboratory research and development to process scale-up, helping customers efficiently advance drug development and industrialization processes.
Why Choose Bioncan
Focused on pharmaceutical intermediates, possessing extensive synthesis experience and technological expertise. Full-scale supply capabilities, covering needs from laboratory to commercial production. Provides complete quality control documentation to ensure controllable and traceable product quality. Supports customized requirements, adjusting purity, impurity control, and packaging solutions as needed. Provides supporting process optimization and scale-up technologies to improve clients' R&D efficiency and commercialization success rates.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 148870-57-9, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.